A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Data Don’t Look Good for Four COVID-19 Treatments


The World Health Organization released preliminary results on the effectiveness of four COVID-19 treatments, and they were lackluster at best. The 11,000-person trial focused on the use of Remdesivir, Hydroxychloroquine, Lopinavir (fixed-dose combination with Ritonavir), and Interferon-β1a among patients with COVID-19 in 400 hospitals across the world. None of the treatments reduced mortality, decreased the need for breathing assistance, or shortened the length of hospital stay.

A preprint of results was released on October 15, with the final data scheduled for publication in The New England Journal of Medicine. Read more here.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy